Research
Advancing Rare Cancer Care: DiCE at the EURACAN Board Meeting
On the 7th and the 8th of November, Laura Urena from Digestive Cancers Europe (DiCE) and a member of EURACAN Patient Advocacy Group (EPAG), partici...
Wolfram Nolte Memorial Award 2024: Celebrating Innovation in Colorectal Cancer Care
The Wolfram Nolte Memorial Award is presented annually to projects that address the unmet needs of patients and carers affected by colorectal cance...
Tevimbra (tislelizumab) Receives New European Recommendations for Oesophageal and Gastric Cancer
Tevimbra (tislelizumab) receives CHMP recommendations for treating PD-L1-positive oesophageal squamous cell carcinoma and gastric/gastroesophageal ...
New Era in Gastric Cancer Treatment: Zolbetuximab Gains EU Approval
On September 20th, 2024, the European Commission approved zolbetuximab with chemotherapy for advanced Gastric and GastroEsophageal Junction cancers...
The POLAR Promise: Groundbreaking Survival Gains for Targeted Pancreatic Cancer Patients in Phase II Trial
Phase II trial of Pembrolizumab Immunotherapy and Olaparib (POLAR) trial new data presented at the European Society for Medical Oncology (ESMO) 202...
PerMICCion: A Study on Transforming Colorectal Cancer Prevention and Treatment through Gut Microbiome Research
A groundbreaking study in Germany, known as PerMICCion, is investigating how understanding the microorganisms in our gut, known as the gut microbio...
Closing the Gap between Hype and Hope: New Report Examines How Health Systems Can Prepare for the Future of Cancer Diagnosis
The Health Policy Partnership (HPP) has worked with an expert steering committee to publish a report outlining the policy actions needed to prepare...
EMA Approves New First-line Treatment Option for Metastatic Pancreatic Cancer
Irinotecan hydrochloride trihydrate (Onivyde pegylated liposomal) was approved in March 2024 by the European Medicines Agency (EMA). Indications: N...
Fruquintinib: A New Medicine for mCRC Recommended for Approval in Europe
DiCE supports the recommendation for approval of fruquintinib, a new medicine for metastatic colorectal cancer (mCRC). This medicine offers mCRC pa...
Extending Colonoscopy Screening Intervals: A New Approach to Colorectal Cancer Prevention
Having a colonoscopy is the best way to check and screen for colorectal cancer (CRC). A small camera on a bendy tube is passed through the anus and...